Net profit of Fortis Malar Hospitals reported to Rs 54.05 crore in the quarter ended March 2024 as against net loss of Rs 6.99 crore during the previous quarter ended March 2023. Sales declined 73.28% to Rs 5.52 crore in the quarter ended March 2024 as against Rs 20.66 crore during the previous quarter ended March 2023.For the full year,net profit reported to Rs 45.32 crore in the year ended March 2024 as against net loss of Rs 15.48 crore during the previous year ended March 2023. Sales declined 31.34% to Rs 59.01 crore in the year ended March 2024 as against Rs 85.95 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales5.5220.66 -73 59.0185.95 -31 OPM %8.883.53 --2.055.32 - PBDT1.851.28 45 1.445.14 -72 PBT0.79-2.17 LP -7.92-7.01 -13 NP54.05-6.99 LP 45.32-15.48 LP Powered by Capital Market - Live News

Fortis Malar Hospitals announced that the Board of Directors of the Company at its meeting held on 17 May 2024, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 25%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Fortis Malar Hospitals will hold a meeting of the Board of Directors of the Company on 17 May 2024Powered by Capital Market - Live News

Fortis Malar Hospitals announced that the Board of Directors of the Company at its meeting held on 12 April 2024, inter alia, have recommended the interim dividend of Rs 40 per equity Share (i.e. 400%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Fortis Malar Hospitals has adjourned the meeting of the Board of Directors which was scheduled to be held on 8 April 2024. The meeting will now be held on 12 April 2024.Powered by Capital Market - Live News